Aspadol 100mg Tablets
Aspadol 100mg is an immediate-release oral tablet containing tapentadol 100mg, a strong opioid analgesic. Tapentadol is used under close professional supervision for acute pain severe enough to require an opioid when alternative treatments are inadequate.
Price: From $150.00
Category: Pain Relief
Brand: Aspadol
SKU: ASP-532
Availability: In Stock
Active Ingredient: Tapentadol Hydrochloride equivalent to Tapentadol 100mg
Dosage Form: Tablets
Indication & Clinical Uses
Acute pain severe enough to require an opioid analgesic Pain for which alternative treatments are inadequate Clinician-directed short-term opioid analgesia
Dosage & Administration Guidance
Use only under the direct supervision of a healthcare professional authorised to prescribe controlled opioid medicines. The dose must be individually selected according to pain severity, previous analgesic exposure, clinical response, risk factors and the ability to monitor the patient. Use the lowest effective dose for the shortest appropriate duration. Do not exceed the prescribed dose or dosing interval. Do not combine with another opioid, sedative, benzodiazepine or alcohol unless specifically directed and monitored by the prescriber. Do not abruptly discontinue tapentadol in a physically dependent patient. An individual gradual taper must be provided by the healthcare professional.
Storage & Handling
Store the tablets at controlled room temperature, 20°C to 25°C / 68°F to 77°F, with permitted excursions between 15°C and 30°C / 59°F and 86°F. Protect from moisture. Keep in a secure place out of the reach of children and unauthorised persons. Do not use tablets after the expiry date or when the blister, seal or tablet appears damaged. Follow applicable drug take-back or disposal requirements for unused controlled medicines.
How to Use & Dosage Guidance
- Obtain a Valid Prescription: Tapentadol must only be used under the direction of a healthcare professional authorised to prescribe controlled opioid medicines.
- Follow the Individual Prescription: Take only the exact dose and dosing interval stated by the prescriber. Do not follow a generic self-dosing schedule.
- Take the Tablet Correctly: Immediate-release tapentadol tablets may be taken with or without food. Swallow the prescribed tablet with water.
- Avoid Dangerous Combinations: Do not combine tapentadol with alcohol, benzodiazepines, sedatives, other opioids or other central-nervous-system depressants unless specifically managed by the prescriber.
- Do Not Stop Abruptly After Regular Use: A physically dependent patient should not suddenly stop tapentadol. Dose reduction or discontinuation must follow an individual tapering plan provided by the prescriber.
- Maintain Secure Storage: Keep the tablets in a locked or otherwise secure location away from children, visitors and anyone for whom the medicine was not prescribed.
Safety Warnings & Precautions
- Tapentadol carries risks of addiction, abuse and misuse that can lead to overdose and death.
- Serious, life-threatening or fatal respiratory depression may occur.
- Accidental ingestion of even one dose can be fatal, particularly in children.
- Use the lowest effective dosage for the shortest appropriate duration.
- Discuss access to naloxone with the prescriber where appropriate.
- Combining tapentadol with benzodiazepines can cause profound sedation, respiratory depression, coma and death.
- Avoid alcohol and other central-nervous-system depressants.
- Do not drive or operate machinery until the medicine’s effects are known.
- Serotonin syndrome may occur with serotonergic medicines.
- Tapentadol may cause severe hypotension and fainting.
- Use caution in patients with head injury or increased intracranial pressure.
- Tapentadol can worsen seizures in susceptible patients.
- Severe constipation and gastrointestinal complications may occur.
- Opioid-induced hyperalgesia may cause worsening or increased sensitivity to pain.
- Prolonged opioid use during pregnancy may cause neonatal opioid withdrawal syndrome.
- Breastfeeding is generally not recommended without specialist assessment.
- Use is not recommended in severe hepatic impairment.
- Use is not recommended in severe renal impairment.
- Do not abruptly discontinue after physical dependence has developed.
- Store securely to prevent theft, accidental ingestion and unauthorised use.
- Selling or giving the medicine to another person may cause serious harm and may be unlawful.
- Verify the exact product, manufacturer, batch and lawful dispensing eligibility before fulfilment.
Contraindications
- Significant respiratory depression
- Acute or severe bronchial asthma in an unmonitored setting or without resuscitative equipment
- Known or suspected gastrointestinal obstruction, including paralytic ileus
- Known hypersensitivity to tapentadol or any tablet ingredient
- Concurrent use of monoamine oxidase inhibitors or MAOI use within the previous 14 days
Drug Interactions
- Benzodiazepines — increased risk of profound sedation, respiratory depression, coma and death
- Alcohol — increased respiratory-depression and overdose risk
- Other opioids — additive sedation and respiratory depression
- Sedatives and hypnotics — increased central-nervous-system depression
- Antipsychotic medicines — increased sedation and respiratory-depression risk
- General anaesthetics — additive respiratory and central-nervous-system depression
- Muscle relaxants — increased respiratory-depression risk
- Monoamine oxidase inhibitors — contraindicated during treatment and for 14 days after MAOI use
- SSRIs — serotonin-syndrome risk
- SNRIs — serotonin-syndrome risk
- Tricyclic antidepressants — serotonin-syndrome and central-nervous-system risk
- Triptans — possible serotonin-syndrome risk
- Mirtazapine — possible serotonin-syndrome risk
- Trazodone — possible serotonin-syndrome risk
- Tramadol — increased serotonergic, seizure and opioid effects
- Mixed opioid agonist-antagonists such as butorphanol, nalbuphine and pentazocine — may reduce analgesia or precipitate withdrawal
- Partial opioid agonists such as buprenorphine — may reduce analgesia or precipitate withdrawal
- Anticholinergic medicines — increased risk of urinary retention and severe constipation
- Diuretics — opioids may reduce diuretic effectiveness
- Recreational sedatives or illicit opioids — potentially fatal additive effects
Potential Side Effects
- Nausea
- Dizziness
- Vomiting
- Somnolence or unusual sleepiness
- Constipation
- Dry mouth
- Indigestion
- Fatigue
- Decreased appetite
- Headache
- Pruritus or itching
- Increased sweating
- Insomnia
- Confusion
- Abnormal dreams
- Anxiety
- Tremor
- Low blood pressure
- Fainting
- Respiratory depression
- Serotonin syndrome
- Seizure
- Severe allergic reaction or anaphylaxis
- Adrenal insufficiency
- Opioid-induced hyperalgesia
- Withdrawal symptoms
- Hallucinations or serious mental-status changes
Frequently Asked Questions
- What is Aspadol 100mg?
- Aspadol 100mg is an immediate-release tablet containing tapentadol 100mg. Tapentadol is a strong opioid analgesic and a Schedule II controlled substance in the United States.
- What is immediate-release tapentadol used for?
- It may be prescribed for acute pain severe enough to require an opioid when alternative treatments are ineffective, not tolerated or otherwise inadequate.
- Is a prescription and eligibility review required?
- Yes. Tapentadol is a Schedule II controlled prescription opioid. Medical assessment, a valid prescription and lawful controlled-substance dispensing are required.
- Can tapentadol be taken with food?
- Immediate-release tapentadol tablets may be taken with or without food. Follow the exact directions supplied by the prescriber.
- Can alcohol be consumed with tapentadol?
- No. Alcohol can increase sedation and respiratory depression and may contribute to overdose, coma or death.
- Who must not use tapentadol?
- Tapentadol is contraindicated in significant respiratory depression, acute or severe bronchial asthma in an unmonitored setting, known or suspected gastrointestinal obstruction, hypersensitivity to tapentadol, and current or recent MAO-inhibitor use.
- Which symptoms require emergency medical care?
- Call emergency services for slow or difficult breathing, extreme sleepiness, inability to wake, blue lips, collapse, seizure, severe allergic reaction or suspected overdose.
- Can tapentadol be stopped suddenly?
- A person who has developed physical dependence should not stop it suddenly. The prescriber should create an individual gradual tapering plan.
- How should tapentadol tablets be stored?
- Store at 20°C to 25°C or 68°F to 77°F, protect from moisture and keep the tablets securely out of the reach of children and unauthorised persons.
- Can it be combined with another opioid or sedative?
- Do not combine tapentadol with another opioid, benzodiazepine, sedative or other central-nervous-system depressant unless specifically directed and monitored by the prescriber.
- Does tapentadol affect driving?
- It may cause sleepiness, dizziness or impaired reactions. Do not drive or operate machinery until the prescriber confirms it is safe and the individual effects are known.
- What should be checked before fulfilment?
- Verify the valid prescription, patient eligibility, exact product and strength, dispensing authority, batch information and all applicable controlled-substance requirements.
Medically reviewed by CureHealth Clinical Review Board. Compliant with standard US pharmacy reference guidelines.